Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health

Abstract

The gut microbiota is composed of a huge number of different bacteria, that produce a large amount of compounds playing a key role in microbe selection and in the construction of a metabolic signaling network. The microbial activities are affected by environmental stimuli leading to the generation of a wide number of compounds, that influence the host metabolome and human health. Indeed, metabolite profiles related to the gut microbiota can offer deep insights on the impact of lifestyle and dietary factors on chronic and acute diseases. Metagenomics, metaproteomics and metabolomics are some of the meta-omics approaches to study the modulation of the gut microbiota. Metabolomic research applied to biofluids allows to: define the metabolic profile; identify and quantify classes and compounds of interest; characterize small molecules produced by intestinal microbes; and define the biochemical pathways of metabolites. Mass spectrometry and nuclear magnetic resonance spectroscopy are the principal technologies applied to metabolomics in terms of coverage, sensitivity and quantification. Moreover, the use of biostatistics and mathematical approaches coupled with metabolomics play a key role in the extraction of biologically meaningful information from wide datasets. Metabolomic studies in gut microbiota-related research have increased, focusing on the generation of novel biomarkers, which could lead to the development of mechanistic hypotheses potentially applicable to the development of nutritional and personalized therapies.

Comprehensive Metabolomic Analysis in Blood, Urine, Fat, and Muscle in Men with Metabolic Syndrome: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Resveratrol after Four Months’ Treatment

“…However, gut bacteria may contribute to their production and degradation [37]. Fermentation of tyrosine and tryptophan by colonic bacteria is found to produce phenols and indoles, which are excreted in the urine [38]. Also, imidazole propionate is known to be excreted in the urine and direct degradation of urocanate to imidazole propionate by the intestinal flora was demonstrated in an animal study [39].…”

The Microbiome and Biomarkers for Necrotizing Enterocolitis: Are We Any Closer to Prediction?

“…Proteomic studies deepen our physiological understanding of diseases by detecting modifications and interactions of proteins and peptides, compared with genomics that give a theoretical functional status of the organism (58). Both proteomics and metabolomics exploit separation techniques prior to mass spectrometry analysis or nuclear magnetic resonance (NMR) for metabolites (59). Depending on the sampling site, metabolites are derived from the human host, diet, or microbiota, adding complexity to source attribution, as bacteria and people share many metabolic pathways (60).…”

Exploring the microbiome in health and disease

“…415 NAFLD: Metabolites like 1-butanol, 2-butanone, and 4-methyl-2-pentanone have been found to be perturbed in people with NAFLD; 415 Neuropathology: Modified levels of free amino acids and SCFAs, tryptophan-nicotinic acid, sulfur metabolic pathways, and urinary metabolites have been recorded in autistic children. 415 Microbial metabolites should be adequately quantified using different methods in order to cover as much as possible of the metabolome and be further correlated against the gene expression levels and the corresponding enzymatic activity of each gene. Preferably, these metabolomics results should be combined and integrated with different "omics" techniques applied to DNA, RNA, and protein to provide a full microbiome analysis.…”